Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
0.925
-0.021 (-2.22%)
At close: Nov 4, 2024, 4:00 PM
0.955
+0.029 (3.18%)
After-hours: Nov 4, 2024, 7:02 PM EST

Microbot Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Selling, General & Admin
4.394.345.775.415.894.37
Upgrade
Research & Development
5.125.517.515.953.22.87
Upgrade
Operating Expenses
9.519.8613.2811.369.097.24
Upgrade
Operating Income
-9.51-9.86-13.28-11.36-9.09-7.24
Upgrade
Interest Expense
-----0.08-0.1
Upgrade
Interest & Investment Income
0.180.230.120.04--
Upgrade
EBT Excluding Unusual Items
-9.32-9.63-13.16-11.31-9.17-7.34
Upgrade
Gain (Loss) on Sale of Assets
-0-0-0.01--0.1
Upgrade
Legal Settlements
-1.11-1.11----
Upgrade
Pretax Income
-10.44-10.74-13.17-11.31-9.17-7.25
Upgrade
Net Income
-10.44-10.74-13.17-11.31-9.17-7.25
Upgrade
Net Income to Common
-10.44-10.74-13.17-11.31-9.17-7.25
Upgrade
Shares Outstanding (Basic)
13107774
Upgrade
Shares Outstanding (Diluted)
13107774
Upgrade
Shares Change (YoY)
63.79%40.49%2.14%-0.14%66.80%41.66%
Upgrade
EPS (Basic)
-0.80-1.05-1.81-1.59-1.29-1.70
Upgrade
EPS (Diluted)
-0.80-1.05-1.81-1.59-1.29-1.70
Upgrade
Free Cash Flow
-7.89-8.57-11.63-9.42-7.34-6.67
Upgrade
Free Cash Flow Per Share
-0.60-0.84-1.60-1.33-1.03-1.56
Upgrade
EBITDA
-9.41-9.75-13.18-11.28-9.02-7.16
Upgrade
D&A For EBITDA
0.10.110.10.080.070.08
Upgrade
EBIT
-9.51-9.86-13.28-11.36-9.09-7.24
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.